Treatment of Reperfusion Event by Vitamin C Infusion (TREVI)
This study is currently recruiting participants.
Verified March 2016 by Francesco Violi, University of Roma La Sapienza
University of Roma La Sapienza
Information provided by (Responsible Party):
Francesco Violi, University of Roma La Sapienza
First received: March 18, 2010
Last updated: March 8, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||December 2018|
|Estimated Primary Completion Date:||October 2017 (Final data collection date for primary outcome measure)|
Pignatelli P, Tanzilli G, Carnevale R, Di Santo S, Loffredo L, Celestini A, Proietti M, Tovaglia P, Mangieri E, Basili S, Violi F. Ascorbic acid infusion blunts CD40L upregulation in patients undergoing coronary stent. Cardiovasc Ther. 2011 Dec;29(6):385-94. doi: 10.1111/j.1755-5922.2010.00168.x. Epub 2010 Jul 12.